Insurance approval of mesenchymal stem cell for acute GVHD in Japan: need of follow up for some remaining concerns
Crossref DOI link: https://doi.org/10.1007/s12185-015-1930-x
Published Online: 2016-01-12
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Miyamura, Koichi
Text and Data Mining valid from 2016-01-12